NOVA LIMA, Brazil--(BUSINESS WIRE)--
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST.
Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.
When will Afya (AFYA) report its Q3 2024 earnings?
Afya will report its third quarter and nine months 2024 financial results on November 13th, 2024, after market close.
What time is Afya's (AFYA) Q3 2024 earnings conference call?
Afya's Q3 2024 earnings conference call and webcast will be held at 05:00 pm EST on November 13th, 2024.
How can investors access Afya's (AFYA) Q3 2024 earnings call?
Investors can access the earnings call through the webcast link on Afya's IR website, or by dialing in using the provided numbers for Brazil and the United States.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.